Literature DB >> 8387765

Intraoperative urinary cyclic AMP monitoring in primary hyperparathyroidism.

W G Schenk1, M Wills, M S MacLeod, J B Hanks.   

Abstract

OBJECTIVE: This study examined the utility of intraoperative urinary cyclic 3'5' adenosine monophosphate (UcAMP), an indicator of parathyroid (PTH) hormone end-organ activity, as a "biochemical frozen section," signaling the real-time resolution of PTH hyperactivity during surgery for primary hyperparathyroidism. SUMMARY BACKGROUND DATA: The unsuccessful initial neck exploration for primary hyperparathyroidism, leaving the patient with persistent hyperfunctioning parathyroid tissue, results in part from the surgeon's inability intraoperatively to correlate a gland's gross appearance and size estimation with physiologic function. Preoperative imaging, intraoperative imaging, and intraoperative histologic/cytologic surveillance have not resolved this dilemma.
METHODS: Twenty-seven patients underwent a prospective intraoperative UcAMP monitoring protocol. The patients all had a clinical diagnosis of primary hyperparathyroidism and an average preoperative serum calcium of 12.0 +/- 0.3 mg/dl. UcAMP was assayed intraoperatively using 20-minute nonequilibrium radioimmunoassay providing real-time feedback to the operating team.
RESULTS: All patients had an elevated UcAMP confirming PTh hyperactivity at the beginning of the procedure. One patient, subsequently found to have an supernumerary ectopic adenoma, had four normal glands identified intraoperatively, and his intraoperative UcAMP values corroborated persistent hyperparathyroidism, the UcAMP of the remaining 26 patients decreased from 7.0 +/- 1.1 to 2.7 +/- 0.7 nm.dl GF (p < .00005) after complete adenoma excision, and they remain normocalcemic. The protocol provided useful and relevant information to the operating team, and aided in surgical decision-making, in 10 of the 27 cases (37%).
CONCLUSION: Intraoperative biochemical surveillance with ucAMP monitoring reliably signals resolution of PTH hyperfunction. It is a useful adjunct to the surgeon's skill, judgment, and experience in parathyroid surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387765      PMCID: PMC1242851          DOI: 10.1097/00000658-199305010-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Enlarged parathyroid glands: high-resolution local coil MR imaging.

Authors:  J B Kneeland; A J Krubsack; T L Lawson; S D Wilson; B D Collier; W Froncisz; A Jesmanowicz; J S Hyde
Journal:  Radiology       Date:  1987-01       Impact factor: 11.105

2.  Causes of failure in operations for hyperparathyroidism.

Authors:  H A Bruining; J C Birkenhäger; G L Ong; S W Lamberts
Journal:  Surgery       Date:  1987-05       Impact factor: 3.982

Review 3.  Primary hyperparathyroidism.

Authors:  S A Wells; G S Leight; A J Ross
Journal:  Curr Probl Surg       Date:  1980-08       Impact factor: 1.909

4.  Urinary cAMP excretion during surgery: an index of successful parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  A M Spiegel; S J Marx; M F Brennan; E M Brown; J O Koehler; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

5.  Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography.

Authors:  G G Winzelberg; J D Hydovitz; K R O'Hara; K M Anderson; E Turbiner; T S Danowski; R D Lippe; G A Melada; A M Harrison
Journal:  Radiology       Date:  1985-04       Impact factor: 11.105

6.  Impact on surgery of preoperative localization of parathyroid lesions with dual radionuclide subtraction scanning.

Authors:  A G Mattar; E S Wright; S M Chittal; C G Kennedy; A H Kwan
Journal:  Can J Surg       Date:  1986-01       Impact factor: 2.089

7.  Intraoperative urinary cyclic adenosine monophosphate as a guide to successful reoperative parathyroidectomy.

Authors:  J A Norton; M F Brennan; A W Saxe; R A Wesley; J L Doppman; A G Krudy; S J Marx; A C Santora; M Hicks; G D Aurbach
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

8.  Comparison of imaging methods for localization of parathyroid tumors.

Authors:  K Kohri; Y Ishikawa; M Kodama; Y Katayama; M Iguchi; S Yachiku; T Kurita
Journal:  Am J Surg       Date:  1992-08       Impact factor: 2.565

9.  Hyperparathyroidism associated with the enlargement of two or three parathyroid glands.

Authors:  S A Wells; G S Leight; M Hensley; W G Dilley
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

10.  Results of reoperation for persistent and recurrent hyperparathyroidism.

Authors:  M F Brennan; S J Marx; J Doppman; J Costa; A Saxe; A Spiegel; A Krudy; G Aurbach
Journal:  Ann Surg       Date:  1981-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.